{"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"groups":[{"description":"Single intravenous administration of rhPSMA-7.3 (18F) for PET Scan\n\nrhPSMA-7.3 (18F) Injection: Radioligand for PET CT scanning\n\nPositron Emission Tomography scan: imaging test with radioligand","id":"BG000","title":"Single Arm"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"6.98","value":"64.9"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"163"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"< 65 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"193"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"≥ 65 years"}],"description":"Age in years split into 2 groups","paramType":"NUMBER","title":"Age, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"356"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"17"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"311"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"28"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}]}],"description":"Ethnicity split into 2 substantive groups and those for whom it was not reported","paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"30"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"Black or African American"},{"categories":[{"measurements":[{"groupId":"BG000","value":"289"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"White"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"Other"},{"categories":[{"measurements":[{"groupId":"BG000","value":"33"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"Not Reported"}],"description":"Race split into 3 substantive categories and also those for whom it was not reported","paramType":"NUMBER","title":"Race/Ethnicity, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"14"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"Netherlands"},{"categories":[{"measurements":[{"groupId":"BG000","value":"238"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"18"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"Finland"},{"categories":[{"measurements":[{"groupId":"BG000","value":"86"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"Germany"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"160"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"=7"},{"categories":[{"measurements":[{"groupId":"BG000","value":"87"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"=8"},{"categories":[{"measurements":[{"groupId":"BG000","value":"97"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"=9"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"=10"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"≤ 6"}],"description":"Gleason score (defined by the International Society of Urological Pathologists) was based on prostate biopsy.\n\nScore 6 - The cells look similar to normal prostate cells. The cancer is likely to grow very slowly, if at all\n\nScore 7 - Most cells still look similar to normal prostate cells. The cancer is likely to grow slowly\n\nScore 8 - Some cells look abnormal. The cancer might grow quickly or at a moderate rate\n\nScore 9 or 10 - The cells look very abnormal. The cancer is likely to grow quickly","paramType":"NUMBER","title":"Total Gleason Score","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"16"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"T1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"T1a"},{"categories":[{"measurements":[{"groupId":"BG000","value":"127"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"T1c"},{"categories":[{"measurements":[{"groupId":"BG000","value":"58"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"T2"},{"categories":[{"measurements":[{"groupId":"BG000","value":"18"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"T2a"},{"categories":[{"measurements":[{"groupId":"BG000","value":"25"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"T2b"},{"categories":[{"measurements":[{"groupId":"BG000","value":"33"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"T2c"},{"categories":[{"measurements":[{"groupId":"BG000","value":"20"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"T3"},{"categories":[{"measurements":[{"groupId":"BG000","value":"21"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"T3a"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"T3b"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"T3c"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"T4"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"TX"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"Missing"}],"description":"Tumour (T) describes the size or area of the cancer\n\nT1 means the cancer is too small to be seen on a scan, or felt during an examination of the prostate\n\nT1a means that the cancer is in less than 5% of the removed tissue\n\nT1c cancers are found by biopsy, for example after a raised PSA level\n\nT2 means the cancer is completely inside the prostate gland\n\nT3a means the cancer has broken through the capsule (covering) of the prostate gland\n\nT3b means the cancer has spread into the tubes that carry semen (seminal vesicles)\n\nT4 means the cancer has spread into other body organs nearby","paramType":"NUMBER","title":"TNM (Tumor-Node-Metastasis) Stage T","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"6"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"=1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"50"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"=2"},{"categories":[{"measurements":[{"groupId":"BG000","value":"110"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"=3"},{"categories":[{"measurements":[{"groupId":"BG000","value":"87"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"=4"},{"categories":[{"measurements":[{"groupId":"BG000","value":"103"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"=5"}],"description":"GGG (defined by the International Society of Urological Pathologists) was based on prostate biopsy.\n\nGroup 1: The cells look similar to normal prostate cells. The cancer is likely to grow very slowly, if at all\n\nGroup 2: Most cells still look similar to normal prostate cells. The cancer is likely to grow slowly\n\nGroup 3: The cells look less like normal prostate cells. The cancer is likely to grow at a moderate rate\n\nGroup 4: Some cells look abnormal. The cancer might grow quickly or at a moderate rate\n\nGroup 5: The cells look very abnormal. The cancer is likely to grow quickly","paramType":"NUMBER","title":"Gleason Grade Group (GGG)","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"290"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"M0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"M1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"M1a"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"M1b"},{"categories":[{"measurements":[{"groupId":"BG000","value":"48"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"MX"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"Missing"}],"description":"Metastasis (M) describes whether the cancer has spread to a different part of the body.\n\nM0 means the cancer hasn't spread to other parts of your body.\n\nM1 means the cancer has spread to other parts of the body outside the pelvis. It is split into M1a, M1b and M1c.\n\nM1a means there are cancer cells in lymph nodes outside the pelvis\n\nM1b means there are cancer cells in the bone\n\nM1c means there are cancer cells in other parts of the body such as the lungs","paramType":"NUMBER","title":"TNM Stage M","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":">1.0 to 2.0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"62"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":">2.0 to 5.0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"134"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":">5.0 to 10.0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"158"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":">10.0"}],"paramType":"NUMBER","title":"Prostate-specific antigen (PSA) Characterization (ng/mL)","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"241"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"High-risk or Veryhigh-risk"},{"categories":[{"measurements":[{"groupId":"BG000","value":"115"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"Immediate-Risk"}],"description":"Baseline Risk Category. High-risk or Very-high risk defined as meeting any one of these criteria: T-stage T3 (including T3a and T3b) or T4, GGG 4 or 5, Primary Gleason pattern 5, or PSA \\>20 ng/mL.","paramType":"NUMBER","title":"Baseline Risk Category","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"284"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"N0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"11"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"N1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"49"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"NX"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}],"title":"Missing"}],"description":"Node (N) describes whether the cancer has spread to the lymph nodes.\n\nN0 means that the nearby lymph nodes don't contain cancer cells\n\nN1 means there are cancer cells in lymph nodes near the prostate","paramType":"NUMBER","title":"TNM Stage N","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"4.341","value":"28.20"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"334"}],"units":"Participants"}]}],"description":"Body mass index on Day 1 (Kg/m2)","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"Number analyzed differs from overall due to missing data.","title":"Body Mass Index","unitOfMeasure":"Kg/m2"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.27","value":"2.9"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}]}],"description":"Time since initial cancer diagnosis relative to the date of informed consent.","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Time since initial cancer diagnosis","unitOfMeasure":"months"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"2.83","value":"2.5"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"354"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"Number analyzed differs from overall due to missing data.","title":"Time since last PSA Measurement","unitOfMeasure":"months"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"18.2450","value":"15.090"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"356"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Last PSA Measurement (ng/mL)","unitOfMeasure":"ng/mL"}],"populationDescription":"The FAS comprised 356 patients who were scheduled to receive the rhPSMA-7.3 (18F) injection and met the inclusion/exclusion criteria"}